ES2136755T3 - Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases. - Google Patents

Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases.

Info

Publication number
ES2136755T3
ES2136755T3 ES95103319T ES95103319T ES2136755T3 ES 2136755 T3 ES2136755 T3 ES 2136755T3 ES 95103319 T ES95103319 T ES 95103319T ES 95103319 T ES95103319 T ES 95103319T ES 2136755 T3 ES2136755 T3 ES 2136755T3
Authority
ES
Spain
Prior art keywords
polymer
formula
pna
opt
synthesis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95103319T
Other languages
English (en)
Inventor
Gerhard Dr Breipohl
Eugen Dr Uhlmann
Jochen Dr Knolle
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2136755T3 publication Critical patent/ES2136755T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/001—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof by chemical synthesis
    • C07K14/003—Peptide-nucleic acids (PNAs)
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G69/00—Macromolecular compounds obtained by reactions forming a carboxylic amide link in the main chain of the macromolecule
    • C08G69/02—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids
    • C08G69/08—Polyamides derived from amino-carboxylic acids or from polyamines and polycarboxylic acids derived from amino-carboxylic acids
    • C08G69/10—Alpha-amino-carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Polymers & Plastics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polyamides (AREA)

Abstract

SE DESCRIBE UN PROCESO PARA LA ELABORACION DE OLIGOMEROS PNA DONDE R0 SIGNIFICA HIDROGENO, ALCANOIL, ALCOXICARBONIL, CICLOALCANOIL, AROIL, HETEROAROIL, O UN GRUPO, QUE ES ADECUADO PARA LA RECEPCION INTRACELULAR DE OLIGOMERO, A Y Q SON RESTOS AMINOACIDOS, K Y L SON 0 HASTA 20, N SIGNIFICA 1 HASTA 50, B ES UNA NUCLEOBASE HABITUAL EN LA QUIMICA DE NUCLEOTIDOS Y Q0 SIGNIFICA OH, NH2 O ALQUILAMINO QUE PUEDE SER SUSTITUIDO POR ON O NH2. CON ELLO SE DESDOBLAN LOS RESTOS AMINOACIDO Y LOS COMPONENTES DONDE PG ES UN GRUPO DE PROTECCION AMINO INESTABLE DE BASE Y B'' ES UNA NUCLEOBASE PROTEGIDA EN AMINOFUNCION EXOCICLICA, EN FORMA DE ETAPAS DE ACUERDO CON EL METODO DE FASE SOLIDA SOBRE UN SOPORTE POLIMERO, QUE ESTA PROVISTO CON UN GRUPO DE ANCLAJE. SIENDO ACOPLADO Y, DESPUES DE TERMINADA LA CONSTITUCION, SE DESDOBLAN LOS COMPUESTOS OBJETIVO POR MEDIO DE UNA REACCION DE DESDOBLAMIENTO DE SOPORTE POLIMERO. SE DESCRIBEN ADEMAS PRODUCTOS INTERMEDIOS DE OLIGOMEROS PNA ASI COMO PROCESO PARA SU ELABORACION.
ES95103319T 1994-03-14 1995-03-08 Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases. Expired - Lifetime ES2136755T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4408533A DE4408533A1 (de) 1994-03-14 1994-03-14 PNA-Synthese unter Verwendung einer basenlabilen Amino-Schutzgruppe

Publications (1)

Publication Number Publication Date
ES2136755T3 true ES2136755T3 (es) 1999-12-01

Family

ID=6512697

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95103319T Expired - Lifetime ES2136755T3 (es) 1994-03-14 1995-03-08 Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases.

Country Status (12)

Country Link
US (2) US6121418A (es)
EP (1) EP0672701B1 (es)
JP (1) JP4098836B2 (es)
AT (1) ATE182602T1 (es)
AU (1) AU683714B2 (es)
CA (1) CA2144473C (es)
DE (2) DE4408533A1 (es)
DK (1) DK0672701T3 (es)
ES (1) ES2136755T3 (es)
FI (1) FI120262B (es)
GR (1) GR3031265T3 (es)
NO (1) NO321035B1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7825215B1 (en) * 1993-04-26 2010-11-02 Peter E. Nielsen Substituted nucleic acid mimics
US6133444A (en) * 1993-12-22 2000-10-17 Perseptive Biosystems, Inc. Synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
EP0840741B1 (en) * 1995-06-07 2004-04-28 Perseptive Biosystems, Inc. Pna-dna chimeras and pna synthons for their preparation
DE19712530A1 (de) * 1997-03-25 1998-10-01 Boehringer Mannheim Gmbh Neue Monomerbausteine zur Markierung von peptidischen Nukleinsäuren
US20030228619A1 (en) * 2002-06-10 2003-12-11 Xenoport, Inc. Peptide nucleic acids as tags in encoded libraries
US20040137469A1 (en) * 2002-09-08 2004-07-15 Casale Ralph A Methods, compositions and libraries pertaining PNA dimer and PNA oligomer synthesis
EP1981507A4 (en) * 2006-02-01 2011-10-19 Merck Sharp & Dohme INHIBITORS OF THE POTASSIUM CANAL
EP3913065A1 (en) 2011-04-08 2021-11-24 Carnegie Mellon University Conformationally-preorganized, minipeg-containing gamma-peptide nucleic acids
CN104211619B (zh) * 2014-08-19 2016-08-17 苏州维泰生物技术有限公司 一种N-(2-Fmoc-氨乙基)甘氨酸甲酯盐酸盐的合成方法
CN110740994A (zh) * 2017-03-23 2020-01-31 特鲁科德基因修复公司 具有受正交保护的酯部分的肽核酸(pna)单体

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUT41715A (en) * 1984-12-28 1987-05-28 Monsanto Co Process for preparing n-substituted alpha-aminoacids and derivatives thereof
DE3635670A1 (de) 1986-10-21 1988-04-28 Hoechst Ag Synthese von peptid-aminoalkylamiden und peptidhydraziden mittels festphasenmethode
DE3713433A1 (de) 1987-04-22 1988-11-03 Werner Grossmann Einrichtung zum entfernen von schmutzteilchen vom plattenzylinder einer offsetdruckmaschine
EP0322348B1 (de) 1987-12-22 1994-02-02 Hoechst Aktiengesellschaft Säurelabile Ankergruppen zur Synthese von Peptidamiden mittels Festphasenmethode
DE4016596A1 (de) 1990-05-23 1991-11-28 Hoechst Ag Ein neues kupplungsreagenz fuer die peptidsynthese
DK51092D0 (da) * 1991-05-24 1992-04-15 Ole Buchardt Oligonucleotid-analoge betegnet pna, monomere synthoner og fremgangsmaade til fremstilling deraf samt anvendelser deraf
US5539082A (en) * 1993-04-26 1996-07-23 Nielsen; Peter E. Peptide nucleic acids
MX9207334A (es) * 1991-12-18 1993-08-01 Glaxo Inc Acidos nucleicos peptidicos y formulacion farma- ceutica que los contiene
US5527675A (en) * 1993-08-20 1996-06-18 Millipore Corporation Method for degradation and sequencing of polymers which sequentially eliminate terminal residues
US5539083A (en) * 1994-02-23 1996-07-23 Isis Pharmaceuticals, Inc. Peptide nucleic acid combinatorial libraries and improved methods of synthesis

Also Published As

Publication number Publication date
JPH07291909A (ja) 1995-11-07
US6316595B1 (en) 2001-11-13
EP0672701A1 (de) 1995-09-20
NO950958D0 (no) 1995-03-13
AU683714B2 (en) 1997-11-20
FI951129A0 (fi) 1995-03-10
JP4098836B2 (ja) 2008-06-11
DE59506432D1 (de) 1999-09-02
EP0672701B1 (de) 1999-07-28
ATE182602T1 (de) 1999-08-15
AU1480095A (en) 1995-09-21
FI120262B (fi) 2009-08-31
US6121418A (en) 2000-09-19
GR3031265T3 (en) 1999-12-31
DE4408533A1 (de) 1995-09-28
CA2144473C (en) 2008-07-15
CA2144473A1 (en) 1995-09-15
NO950958L (no) 1995-09-15
NO321035B1 (no) 2006-03-06
FI951129A (fi) 1995-09-15
DK0672701T3 (da) 2000-01-03

Similar Documents

Publication Publication Date Title
NO950957D0 (no) PNA-syntese ved anvendelse av en labil amino-beskyttelsesgruppe
ES2136755T3 (es) Sintesis de acidos nucleicos peptidicos (pna) con utilizacion de un grupo protector de amino inestable frente a bases.
HUP0102900A2 (hu) Javított szilárd fázisú peptidszintézis és a szintézisben alkalmazható anyagok
Geckeler Soluble polymer supports for liquid-phase synthesis
JP2011530523A (ja) 酢酸グラチラマーの合成
CA2210031A1 (en) Solid phase synthesis of oligonucleotides
BR9302808A (pt) Processo para preparar polimeros de polissuccinimida
DE59608867D1 (de) Verfahren zur Herstellung substituierter N-Ethyl-Glycinderivate
MX9606636A (es) Poliaspartatos reticulados solubles.
ATE181727T1 (de) Verfahren zur herstellung substituierter aromatischer amine
EP1565486A2 (en) Process for the preparation of glatiramer acetate by polymerisation of n-carboxy anhydrides of l-alanine, l-tyrosine, benzyl l-glutamate and benzyloxycarbonyl l-lysine
Wang et al. Solid phase synthesis of neutral oligonucleotide analogues
Uhlmann et al. Synthesis of polyamide nucleic acids (PNAs), PNA/DNA-chimeras and phosphonic ester nucleic acids (PHONAs)
Wada et al. Functionalization of solid supports with N-unprotected deoxyribonucleosides
Greiner et al. Influence of the Type of Junction in DNA‐3′‐Peptide Nucleic Acid (PNA) Chimeras on Their Binding Affinity to DNA and RNA
Adamiak et al. STUDIES ON OLIGORIBONUCLEOTIDES
JPS6163696A (ja) 新しいペプチド
Mei et al. Figure 14 E xamples of multiple-component reactions for both solid-phase and solution-phase synthesis of heterocycles.
UY25090A1 (es) Un procedimiento para preparar eprosartano
CS260187B1 (cs) Způsob výroby polyaramidů
KR960010672A (ko) 6-옥소-(6H)- 디벤즈-[c,e][1,2]- 옥사포스포린의 제조 방법
ES2136892T3 (es) Polimeros modificados.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 672701

Country of ref document: ES